Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Mega Genomics Limited ( (HK:6667) ) has shared an update.
Mega Genomics Limited has announced a delay in the dispatch of a circular related to the proposed dismissal of their current auditor due to ongoing discussions with a potential new auditor. This delay has also resulted in the continued suspension of trading of the company’s shares on the Hong Kong Stock Exchange, which has been in effect since April 1, 2025. The company advises shareholders and prospective investors to exercise caution when dealing with its shares.
More about Mega Genomics Limited
Mega Genomics Limited is a company incorporated in the Cayman Islands, operating within the genomics industry. The company is listed on the Hong Kong Stock Exchange and is involved in providing genomic services and products.
Average Trading Volume: 27,800
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.61B
Find detailed analytics on 6667 stock on TipRanks’ Stock Analysis page.

